75 results
Page 2 of 4
S-8
EX-99.1
hz8tbwvn
31 Aug 22
Registration of securities for employees
4:32pm
8-K
EX-99.1
1fg7t1s3jyg
27 Jun 22
Entry into a Material Definitive Agreement
7:31pm
8-K
EX-99.1
dqb63t8faid3oomuxcoi
16 Jun 22
Other Events
7:00am
POS AM
nbkk7aukf k47ub1wj
28 Feb 22
Prospectus update (post-effective amendment)
5:46pm
POSASR
otdefxj7pvd
28 Feb 22
Automatic shelf registration (post-effective amendment)
4:16pm
8-K
EX-99.1
c96atx3viuj87fn
10 Jan 22
Regulation FD Disclosure
7:01am
8-K
EX-99.2
madzstsheuv7wypq0q
5 Jan 22
Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
5:27pm
8-K
llg22b
5 Jan 22
Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
5:27pm
8-K
EX-99.1
ga7sn
5 Jan 22
Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
5:27pm
8-K
EX-99.2
pwvkxeebkz8hp5p3usnl
10 Nov 21
Sutro Biopharma Reports Third Quarter 2021 Financial Results, Business Highlights, and Anticipated 2021 Milestones
7:03am
S-8
EX-99.1
0lpew
9 Aug 21
Registration of securities for employees
12:00am
8-K
EX-99.2
zwwax8 p760
19 May 21
Regulation FD Disclosure
5:00pm